In line with these findings, we found that FGF21 treatment increased circulatory SDF‐1 concentrations (Figure 3E) in T1DM mice and enhanced EPC mobilization and infiltration into ischaemic tissue (Figure 3A,B); the role of HIF1‐a stability in this process needs further investigation. Here, FGF21 is linked to type 1 diabetes mellitus.